Publication
Commonwealth anti-corruption body to cover private companies
The Bill delivers on Labor’s election commitment to establish an independent anti-corruption body with public hearings and Royal Commission level powers.
The Life Sciences Law Review - 4th Edition
Global | Publication | March 2016
The fourth edition of the Life Sciences Law Review provides an overview of legal issues of interest to pharmaceutical, biotechnology and medical device companies in 30 jurisdictions. As before, each chapter contains information on legal requirements relating to the key stages in the life cycle of a regulated product, from discovery, through the clinical development process, registration, manufacturing and promotion, plus other issues of special interest, such as pricing and reimbursement, special liability regimes, competition and commercial transactions in the context of the medical products business. Each of the chapters has been prepared by a recognised expert in the relevant jurisdiction, and the resulting work product will assist industry lawyers, regulatory affairs staff and others who need to have an understanding of the issues in each major market.
Contacts
Director: Global Head of Consumer Markets
Partner, Lawyer, Trademark Agent
Global Co-Head of Life Sciences and Healthcare; Partner
Recent publications
Publication
Are we (virtually) there yet?
We are now almost one year on from Mark Zuckerberg’s much talked-about October 2021 letter announcing, among other things, the change of the name of his company from Facebook to Meta, reflecting the company’s commitment to revolutionising social connection through virtual reality.
Publication
Climate change litigation update
Since our last update, the growth in climate change litigation globally has continued. While cases against the fossil fuel sector continue to be brought, there are also claims against defendants in a wider variety of high-emitting and resource-intensive sectors.
Subscribe and stay up to date with the latest legal news, information and events...